GW Pharmaceuticals plc Company Profile (LON:GWP)

About GW Pharmaceuticals plc

GW Pharmaceuticals plc logoGW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: GWP
  • CUSIP:
Key Metrics:
  • Previous Close: $8.96
  • 50 Day Moving Average: $810.635
  • 200 Day Moving Average: $650.905
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for GW Pharmaceuticals plc (LON:GWP) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: GBX 835

Analysts' Ratings History for GW Pharmaceuticals plc (LON:GWP)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016Numis Securities LtdReiterated RatingHoldGBX 835View Rating Details
3/14/2016Peel HuntReiterated RatingUnder ReviewView Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for GW Pharmaceuticals plc (LON:GWP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for GW Pharmaceuticals plc (LON:GWP)
Current Year EPS Consensus Estimate: $-31.300 EPS

Dividends

Dividend History for GW Pharmaceuticals plc (LON:GWP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GW Pharmaceuticals plc (LON:GWP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2016Tom LynchInsiderSell2,074GBX 790£16,384.60
10/28/2016Geoffrey GuyInsiderSell31,682GBX 790£250,287.80
10/27/2016Geoffrey GuyInsiderSell138,318GBX 804£1,112,076.72
10/26/2016Geoffrey GuyInsiderSell130,000GBX 808£1,050,400
10/25/2016Geoffrey GuyInsiderSell125,000GBX 809£1,011,250
10/24/2016Geoffrey GuyInsiderSell68,900GBX 824£567,736
5/11/2016Guy,GeoffreyInsiderSell300,000GBX 444£1,332,000
5/10/2016Lynch ,TomInsiderSell50,000GBX 441£220,500
3/31/2016Wright,StephenInsiderSell58,200GBX 435£253,170
12/18/2015Guy,GeoffreyInsiderSell6,000GBX 366£21,960
12/10/2015Lynch ,TomInsiderSell4,270GBX 451£19,257.70
6/12/2015James NobleInsiderSell20,000GBX 636£127,200
6/11/2015Stephen WrightInsiderSell170,400GBX 641£1,092,264
2/9/2015Christopher John ToveyInsiderSell10,000GBX 404.20£40,420
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GW Pharmaceuticals plc (LON:GWP)
DateHeadline
thestreet.com logoGW Pharmaceuticals Is Set to Benefit as Cannabis Takes on Cancer (LON:GWP)
www.thestreet.com - February 9 at 6:25 PM
feeds.benzinga.com logoGW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017 (LON:GWP)
feeds.benzinga.com - January 30 at 8:12 AM
fool.com logo3 Big Risks for Marijuana Stocks in 2017 (LON:GWP)
www.fool.com - January 23 at 4:00 PM
seekingalpha.com logoGW Pharma Cannabinoid Pipeline Undervalued By The Market - Seeking Alpha (LON:GWP)
seekingalpha.com - December 14 at 6:16 PM
News IconGW Pharmaceuticals plc's Trend Down, Especially After Today's Weak Session (LON:GWP)
flapship.com - December 6 at 10:38 AM
fool.com logoThis Marijuana Stock's Sales Are Shrinking: Should We Care? (LON:GWP)
www.fool.com - December 6 at 10:38 AM
finance.yahoo.com logoGW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss (LON:GWP)
finance.yahoo.com - December 6 at 10:38 AM
sg.finance.yahoo.com logoGW Pharmaceuticals reports 4Q loss (LON:GWP)
sg.finance.yahoo.com - December 5 at 11:14 AM
finance.yahoo.com logoGW Pharma Impresses Analysts With Phase 3 Trial Data (LON:GWP)
finance.yahoo.com - December 5 at 11:14 AM
finance.yahoo.com logoGW Pharma (GWPH) Posts Narrower-than-Expected Loss in Q4 (LON:GWP)
finance.yahoo.com - December 5 at 11:14 AM
finance.yahoo.com logoGW Pharmaceuticals Shows Smaller Than Expected Q4 Loss (LON:GWP)
finance.yahoo.com - December 5 at 11:14 AM
globenewswire.com logoGW Pharmaceuticals plc Announces Epidiolex® (cannabidiol) Data ... - GlobeNewswire (press release) (LON:GWP)
globenewswire.com - December 1 at 10:44 AM
lse.co.uk logoNotice of Q4 and year-end results - London South East (registration) (blog) (LON:GWP)
www.lse.co.uk - November 30 at 10:42 PM
News IconGW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 - PharmiWeb.com (press release) (LON:GWP)
www.pharmiweb.com - November 30 at 10:42 PM
News IconGW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 - ForexTV.com (LON:GWP)
forextv.com - November 30 at 9:16 AM
fool.com logo3 Healthcare Stocks Investors Have Been Thankful for This Year (LON:GWP)
www.fool.com - November 29 at 4:53 PM
fool.com logo3 Healthcare Stocks Investors Have Been Thankful for This Year (LON:GWP)
www.fool.com - November 29 at 4:53 PM
fool.com logoWhy this Marijuana Stock Was a Top Stock So Far in 2016 (LON:GWP)
www.fool.com - November 29 at 4:53 PM
fool.com logoWhy this Marijuana Stock Was a Top Stock So Far in 2016 (LON:GWP)
www.fool.com - November 29 at 4:53 PM
feeds.benzinga.com logoConcerns Over GW Pharma's Epilepsy Drug-On-Drug Interactions Might Be Overblown (LON:GWP)
feeds.benzinga.com - November 23 at 1:25 PM
capitalcube.com logoETFs with exposure to GW Pharmaceuticals Plc : November 22, 2016 (LON:GWP)
www.capitalcube.com - November 22 at 5:16 PM
News IconGW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November - EconoTimes (LON:GWP)
www.econotimes.com - November 22 at 8:50 AM
finance.yahoo.com logoGW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November (LON:GWP)
finance.yahoo.com - November 22 at 8:50 AM
capitalcube.com logoGW Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : GWP-GB : November 21, 2016 (LON:GWP)
www.capitalcube.com - November 21 at 10:27 AM
seekingalpha.com logoAssociated British Foods: There's A New Cannabis Cultivator In Town (LON:GWP)
seekingalpha.com - November 9 at 9:37 AM
lse.co.uk logoDirector Stock Trading Plan - London South East (registration) (blog) (LON:GWP)
www.lse.co.uk - October 29 at 5:08 PM
News IconIs GW Pharmaceuticals plc (AIM:GWP) worth £8.32 based on its intrinsic value? - Simply Wall St (LON:GWP)
simplywall.st - October 22 at 9:34 AM
News IconGW Pharmaceuticals: Intention to Trade Exclusively on NASDAQ (LON:GWP)
www.investegate.co.uk - October 19 at 5:42 PM
capitalcube.com logoETF’s with exposure to GW Pharmaceuticals Plc : October 18, 2016 (LON:GWP)
www.capitalcube.com - October 18 at 5:19 PM
lse.co.uk logoDirector Stock Trading Plan - Regulatory News, RNS - London ... - London South East (registration) (blog) (LON:GWP)
www.lse.co.uk - October 7 at 10:20 AM
News IconGW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome (LON:GWP)
www.drugs.com - October 3 at 9:57 AM
News IconGW Pharmaceuticals PLC- (GWPH) Price Target Raised to $182.00 at Cantor Fitzgerald (LON:GWP)
alltechnews.org - September 27 at 5:20 PM
proactiveinvestors.co.uk logoGW Pharmaceuticals data the "most convincing so far", says City heavyweight (LON:GWP)
www.proactiveinvestors.co.uk - September 27 at 5:20 PM
proactiveinvestors.co.uk logoGW Pharmaceuticals seizure drug aces phase three trial - Proactive Investors UK (LON:GWP)
www.proactiveinvestors.co.uk - September 27 at 9:57 AM
finance.yahoo.com logoGW Pharma Attains 52-Week High on Positive Epidiolex Data (LON:GWP)
finance.yahoo.com - September 27 at 9:57 AM
News IconGW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex(R) (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome (LON:GWP)
pipelinereview.com - September 26 at 5:29 PM
ft.com logoSecond Positive Phase 3 Trial for Epidiolex in LGS (LON:GWP)
announce.ft.com - September 26 at 10:00 AM
rttnews.com logoGW Reports Positive Phase 3 Pivotal Trial For Epidiolex In Treatment Of LGS (LON:GWP)
www.rttnews.com - September 26 at 10:00 AM
feeds.benzinga.com logoGW Pharma's Epidiolex Hits Phase 3 Primary Endpoint For Treating Lennox-Gastaut Syndrome (LON:GWP)
feeds.benzinga.com - September 26 at 8:27 AM
reuters.com logoExclusive: Vanda Pharmaceuticals prepares to explore a sale - sources (LON:GWP)
www.reuters.com - September 22 at 5:26 PM
News IconAerie Pharmaceuticals shares rocket as investors eye-up drug trial (LON:GWP)
www.onenewspage.com - September 15 at 5:44 PM
finance.yahoo.com logoWill GW Pharmaceuticals (GWPH) Continue to Surge Higher? (LON:GWP)
finance.yahoo.com - September 14 at 5:26 PM
proactiveinvestors.co.uk logoSoaring cannabis stock primed and ready for a take-out (LON:GWP)
www.proactiveinvestors.co.uk - September 10 at 9:49 AM
capitalcube.com logoGW Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : GWP-GB : September 9, 2016 (LON:GWP)
www.capitalcube.com - September 9 at 10:04 AM
ft.com logoTotal Issued Share Capital (LON:GWP)
announce.ft.com - September 1 at 8:16 AM
capitalcube.com logoETF’s with exposure to GW Pharmaceuticals Plc : August 23, 2016 (LON:GWP)
www.capitalcube.com - August 23 at 5:32 PM
capitalcube.com logoGW Pharmaceuticals Plc :GWP-GB: Earnings Analysis: Q3, 2016 By the Numbers : August 19, 2016 (LON:GWP)
www.capitalcube.com - August 19 at 8:17 AM
capitalcube.com logoETF’s with exposure to GW Pharmaceuticals Plc : August 12, 2016 (LON:GWP)
www.capitalcube.com - August 12 at 5:24 PM
capitalcube.com logoGW Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : GWP-GB : August 11, 2016 (LON:GWP)
www.capitalcube.com - August 11 at 8:20 AM
247wallst.com logoTwo Polar Opposite Views on GW Cannabinoid Drug Upside (LON:GWP)
247wallst.com - August 10 at 5:38 PM

Social

What is GW Pharmaceuticals plc's stock symbol?

GW Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "GWP."

Where is GW Pharmaceuticals plc's stock going? Where will GW Pharmaceuticals plc's stock price be in 2017?

1 brokerages have issued 1 year price targets for GW Pharmaceuticals plc's shares. Their forecasts range from GBX 835 to GBX 835. On average, they expect GW Pharmaceuticals plc's share price to reach GBX 835 in the next twelve months.

When will GW Pharmaceuticals plc announce their earnings?

GW Pharmaceuticals plc is scheduled to release their next quarterly earnings announcement on Wednesday, February, 8th 2017.

How do I buy GW Pharmaceuticals plc stock?

Shares of GW Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of GW Pharmaceuticals plc stock cost?

One share of GW Pharmaceuticals plc stock can currently be purchased for approximately GBX 716.60.


Last Updated on 2/19/2017 by MarketBeat.com Staff